Data as of Mar 07
| -0.11 / -0.71%|
The 3 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 15.50. The median estimate represents a +16.20% increase from the last price of 15.49.
The current consensus among 4 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.